SET/TAF-I antibody
Quick Overview for SET/TAF-I antibody (ABIN760166)
Target
See all SET/TAF-I (SET) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SET
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1:100-1000, FCM: 1:20-100, IHC-P: 1:100-500, IF(IHC-P): 1:50-200
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Alternative Name
- Set
-
Background
- Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,
-
Gene ID
- 6418
-
UniProt
- Q01105
-
Pathways
- Apoptosis
Target
-